170 related articles for article (PubMed ID: 6293990)
21. Immunopathologic events at the endplate in myasthenia gravis.
Ashizawa T; Appel SH
Springer Semin Immunopathol; 1985; 8(3):177-96. PubMed ID: 2413561
[No Abstract] [Full Text] [Related]
22. Myasthenia gravis (first of two parts).
Drachman DB
N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
[No Abstract] [Full Text] [Related]
23. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
24. [Myasthenia, a model of a disease caused by auto-antibodies].
Goulon M; Gajdos P; Goulon-Goëau C
Ann Med Interne (Paris); 1987; 138(6):444-61. PubMed ID: 2829682
[No Abstract] [Full Text] [Related]
25. Postsynapic membrane of Torpedo electroplax: acetylcholine receptor localization and its use as a tool in the study of cellular immuninty in myasthenia gravis.
Conti-Tronconi B; Morgutti M; Gotti C; Clementi F
Adv Cytopharmacol; 1979; 3():255-67. PubMed ID: 382788
[No Abstract] [Full Text] [Related]
26. The immunopathology of acquired myasthenia gravis.
Engel AG; Sahashi K; Fumagalli G
Ann N Y Acad Sci; 1981; 377():158-74. PubMed ID: 6951470
[TBL] [Abstract][Full Text] [Related]
27. Short review of progress in experimental myasthenia gravis, bearing on the pathogenesis of myasthenia gravis.
Heilbronn E
Prog Brain Res; 1979; 49():459-63. PubMed ID: 390612
[No Abstract] [Full Text] [Related]
28. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2.
Simpson JA
Muscle Nerve; 1978; 1(2):151-6. PubMed ID: 220530
[TBL] [Abstract][Full Text] [Related]
29. [Conceptual aspects of myasthenia gravis].
Ledro Molina D; Avilés Mejías S; Garrido Peralta M
Rev Clin Esp; 1981 Oct; 163(1):13-6. PubMed ID: 6276939
[No Abstract] [Full Text] [Related]
30. Disordered immunologic regulation and autoimmunity.
Talal N
Birth Defects Orig Artic Ser; 1978; 14(5):197-207. PubMed ID: 210857
[No Abstract] [Full Text] [Related]
31. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
Lindstrom J
Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
[No Abstract] [Full Text] [Related]
32. Myasthenia gravis.
Sen S; Banerjee TK
J Assoc Physicians India; 1995 Jul; 43(7):487-93. PubMed ID: 8713224
[No Abstract] [Full Text] [Related]
33. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
[TBL] [Abstract][Full Text] [Related]
34. Experimental autoimmune myasthenia gravis and cholinergic ionophore: an electrophysiologic study.
Takamori M; Mori M; Kasai M
Neurology; 1979 Jul; 29(7):945-50. PubMed ID: 572943
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of myasthenia gravis as a disorder of acetylcholine receptors.
Drachman DB; Pestronk A; Stanley EF
Adv Cytopharmacol; 1979; 3():237-44. PubMed ID: 382787
[No Abstract] [Full Text] [Related]
36. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis.
Sahashi K; Engel AG; Lambert EH; Howard FM
J Neuropathol Exp Neurol; 1980 Mar; 39(2):160-72. PubMed ID: 7373347
[TBL] [Abstract][Full Text] [Related]
37. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 1.
Simpson JA
Muscle Nerve; 1978; 1(1):45-56. PubMed ID: 377070
[TBL] [Abstract][Full Text] [Related]
38. [Disorders of receptor function as a pathogenetic principle in myasthenia gravis].
Toyka KV
Internist (Berl); 1988 Jun; 29(6):414-9. PubMed ID: 3042682
[No Abstract] [Full Text] [Related]
39. [The evidence of antibodies against motor endplates of the skeletal muscle in myasthenia gravis with the double immune-fluorescence technique (author's transl)].
Storch W; Trautmann B
Acta Histochem; 1981; 69(1):18-22. PubMed ID: 6795885
[TBL] [Abstract][Full Text] [Related]
40. Current concepts of pathogenesis and treatment of myasthenia gravis.
Elias SB; Appel SH
Med Clin North Am; 1979 Jul; 63(4):745-57. PubMed ID: 89275
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
